AU7726094A - Peptide compositions capable of down regulating an antigen specific immune response - Google Patents

Peptide compositions capable of down regulating an antigen specific immune response

Info

Publication number
AU7726094A
AU7726094A AU77260/94A AU7726094A AU7726094A AU 7726094 A AU7726094 A AU 7726094A AU 77260/94 A AU77260/94 A AU 77260/94A AU 7726094 A AU7726094 A AU 7726094A AU 7726094 A AU7726094 A AU 7726094A
Authority
AU
Australia
Prior art keywords
composition
peptide
protein
genus
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU77260/94A
Other languages
English (en)
Inventor
Malcolm L. Gefter
Malcolm Morville
Ze'ev Shaked
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immulogic Pharmaceutical Corp
Original Assignee
Immulogic Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immulogic Pharmaceutical Corp filed Critical Immulogic Pharmaceutical Corp
Publication of AU7726094A publication Critical patent/AU7726094A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU77260/94A 1994-09-02 1994-09-02 Peptide compositions capable of down regulating an antigen specific immune response Abandoned AU7726094A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1994/010262 WO1996007428A1 (en) 1994-09-02 1994-09-02 Peptide compositions capable of down regulating an antigen specific immune response

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU15291/00A Division AU748104B2 (en) 1994-09-02 2000-02-10 Peptide compositions capable of down regulating an antigen specific immune response

Publications (1)

Publication Number Publication Date
AU7726094A true AU7726094A (en) 1996-03-27

Family

ID=22242963

Family Applications (1)

Application Number Title Priority Date Filing Date
AU77260/94A Abandoned AU7726094A (en) 1994-09-02 1994-09-02 Peptide compositions capable of down regulating an antigen specific immune response

Country Status (6)

Country Link
EP (1) EP0783322A1 (de)
JP (1) JPH10505356A (de)
AU (1) AU7726094A (de)
CZ (1) CZ63297A3 (de)
NZ (1) NZ273815A (de)
WO (1) WO1996007428A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE296444T1 (de) * 1996-03-21 2005-06-15 Circassia Ltd Kryptische peptide und verfahren zu ihrer identifizierung
DE10359352A1 (de) * 2003-12-16 2005-07-21 Merck Patent Gmbh DNA-Sequenz und rekombinante Herstellung des Graspollen-Allergens Lol p 4
AU2006224529B2 (en) 2005-03-18 2012-05-24 Cytos Biotechnology Ag Cat allergen fusion proteins and uses thereof
GB0710529D0 (en) 2007-06-01 2007-07-11 Circassia Ltd Vaccine
GB0821806D0 (en) 2008-11-28 2009-01-07 Circassia Ltd Compositions with reduced dimer formation
US8835603B2 (en) 2008-11-30 2014-09-16 Immusant, Inc. Agents for the treatment of celiac disease
EP3043812A1 (de) 2013-09-10 2016-07-20 Immusant Inc. Dosierung einer glutenpeptidzusammensetzung
WO2016054038A1 (en) 2014-09-29 2016-04-07 Immusant, Inc. Use of hla genetic status to assess or select treatment of celiac disease

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993021321A2 (en) * 1992-04-09 1993-10-28 Immulogic Pharmaceutical Corporation T CELL EPITOPES OF THE MAJOR ALLERGENS FROM $i(AMBROSIA ARTEMISIIFOLIA)
WO1994011512A2 (en) * 1992-11-12 1994-05-26 Immulogic Pharmaceutical Corporation Allergenic proteins and peptides from japanese cedar pollen
WO1994021675A2 (en) * 1993-03-12 1994-09-29 Immulogic Pharmaceutical Corporation T cell epitopes of ryegrass pollen allergen
CA2164326A1 (en) * 1993-06-02 1994-12-08 Wayne Robert Thomas Cryptic peptides for use in inducing immunologic tolerance
NZ271818A (en) * 1993-08-13 1997-11-24 Immulogic Pharma Corp T cell epitopes of ryegrass pollen antigen

Also Published As

Publication number Publication date
EP0783322A1 (de) 1997-07-16
JPH10505356A (ja) 1998-05-26
WO1996007428A1 (en) 1996-03-14
NZ273815A (en) 1999-05-28
CZ63297A3 (en) 1997-08-13

Similar Documents

Publication Publication Date Title
US6759234B1 (en) Compositions and methods for administering to humans, peptides capable of down regulating an antigen specific immune response
Focke et al. Developments in allergen‐specific immunotherapy: from allergen extracts to allergy vaccines bypassing allergen‐specific immunoglobulin E and T cell reactivity
EP1453539B1 (de) Immunotherapeutische methoden und systeme
KR101699554B1 (ko) 백신용 펩티드
Schall et al. Peptide-based approaches to treat lupus and other autoimmune diseases
JP2015521467A (ja) アレルギー治療のための核酸
JP5926198B2 (ja) カバノキアレルギーに対するワクチン用ペプチド
Hoyne et al. Inhibition of T-cell responses by feeding peptides containing major and cryptic epitopes: studies with the Der p I allergen.
CA2377530A1 (en) Compositions and methods for the treatment or prevention of autoimmune disorders
AU674584B2 (en) Cryptic peptides for use in inducing immunologic tolerance
EP0787147A1 (de) Zhusammensetzung und behandlung von multisklerose
WO1996012737A9 (en) Compositions and treatment for multiple sclerosis
JP2607751B2 (ja) 自己免疫性ブドウ膜網膜炎の治療予防薬
JP2017520509A (ja) 自己免疫性１型糖尿病の免疫調節療法
AU7726094A (en) Peptide compositions capable of down regulating an antigen specific immune response
AU748104B2 (en) Peptide compositions capable of down regulating an antigen specific immune response
KR20000053216A (ko) 펩티드 면역 요법 치료제
Movérare Immunological mechanisms of specific immunotherapy with pollen vaccines: implications for diagnostics and the development of improved vaccination strategies
JPH10506877A (ja) ライグラス花粉アレルゲンのｔ細胞エピトープ
JP6353510B2 (ja) アレルギー治療のための核酸
HUT77806A (hu) Antigénspecifikus immunválaszt alulszabályozó peptidkészítmények
EP1430904A1 (de) Desensibilisatoren
CA2198869A1 (en) Peptide compositions capable of down regulating an antigen specific immune response
PT1434793E (pt) Alérgenos recombinantes com ligação a ige reduzida, mas com antigenicidade de células t não diminuída
AU2003203987B2 (en) Methods and compositions for desensitisation

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted